Regeneus news

  • Tuesday, 24 March 2020

    Regeneus receives milestone payment from Kyocera

    Australian biotechnology and life sciences online news source, BiotechDaily, reported that Regeneus received a non-refundable milestone payment of approximately $1.6 million (100 million Japanese Yen) from Kyocera Corporation as set out in the non-binding Memorandum of Understanding (MOU) signed on 2 March 2020.

  • Thursday, 8 August 2019

    Dr Boreham's Crucible: Regeneus

    Biotech Daily: Dr Boreham’s Crucible: Regeneus

    By TIM BOREHAM

    Flush with fresh funding, the stem cell play’s overhauled management is supremely confident of striking a partnering deal in Japan pertaining to its lead osteoarthritis treatment Progenza.

  • Thursday, 23 May 2019

    90 Seconds With...Dr Alan Dunton

    Interview with STOCKHEAD

    Got 90 seconds? Then listen to Regeneus’ new board appointment Dr. Alan Dunton explain the opportunity presented by the global neuropathic pain market and Regeneus’ unique cell therapy offering.